HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2010, 12, 1 (pages: 25 - 32)

Urine Labelling Marker System for Drug Testing Improves Patient Compliance

Simojoki K., Alho A.

Summary: Urine drug testing plays an important role in substance abuse treatments. When strictly controlled, as it often is, urine sampling creates a humiliating situation and ties up resources. A new sample labelling method has been developed to make supervision unnecessary. This innovation is achieved by labelling the urine with polyethylene glycols. In this study, 57 patients who required urine sampling were randomized into two groups, the traditional supervised (TS) group and the new marker (NM) group. The urine test return rate was 98.3% in the NM group and 100% in the TS group. Attempts to manipulate the urine samples were discovered in 2% of the NM group and 0% of the TS group. Most patients preferred the NM testing method. The personnel too preferred the NM system, and estimated that it reduced their workload dedicated to drug screening by 50%. We conclude that the NM method is more acceptable to patients and personnel, and may increase compliance as a result.

 

AU-CNS Associazione per lā€™Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 ā€“ 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 ā€“ Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page